Detalhe da pesquisa
1.
Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma.
Radiology
; 295(3): 651-661, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286191
2.
Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies.
Eur J Nucl Med Mol Imaging
; 46(6): 1391-1392, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30888476
3.
Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab.
J Nucl Med
; 61(5): 649-654, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628220